Evidence map›Paper›PMID 39894604›Full record

ReviewVirology2025

STAT1 and herpesviruses: Making lemonade from lemons.

Erika R Johansen, Vera L Tarakanova

Abstract readReview
In one paragraph

Review in Virology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Erika R JohansenDepartment of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI, USA.
Vera L TarakanovaDepartment of Microbiology and Immunology, Medical College of Wisconsin, Milwaukee, WI, USA. Electronic address: vera@mcw.edu.

Funding

Gammaherpesvirus protein kinase: a master manipulator of the host during chronic infection.R01AI165578 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI Vera L. Tarakanova · 2022 to 2026
$2.3M
From friend to foe: proviral role of IRF-3 in chronic gammaherpesvirus infectionR21AI182596 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI TARAKANOVA, VERA L. · 2024 to 2025
$440k
Uncovering the proviral role of B cell-intrinsic STAT1 expression during chronic gammaherpesvirus infectionF31AI191670 · NIAID · MEDICAL COLLEGE OF WISCONSIN · PI Erika R Johansen · 2025 to 2026
$100k
NIAID NIH HHS F31 AI191670NIAID NIH HHS R01 AI165578NIAID NIH HHS R21 AI182596
6 · The paper itself

Abstract

Signal transducer and activator of transcription 1 (STAT1) is engaged downstream of interferon and other cytokine receptors and has traditionally been defined as an antiviral effector of the host. Consistent with the antiviral role, genetic deficiency of STAT1 leads to increased replication of diverse viruses and severe disease that can lead to host's mortality, including in rare human cases of STAT1 insufficiency. Surprisingly, excessive STAT1 activation recently identified in patients with heterozygous gain-of-function STAT1 mutations and subsequently modeled in laboratory mice, also leads to poor control of select virus infections, including herpesviruses. Thus, the function of STAT1 in viral infections might be more nuanced and extend beyond the canonical antiviral role of this host factor. This review will compare the findings in the animal models and human cases to discuss the role of STAT1 in herpesvirus infection of the intact host, including the emerging cell type-specific proviral roles of STAT1.

Indexed as

HerpesviridaeHerpesviridae InfectionsHost-Pathogen InteractionsSTAT1 Transcription FactorAnimalsDisease Models, AnimalHumansMiceVirus ReplicationSTAT1 protein, humanSTAT1 Transcription FactorAcute replicationB cell responsesChronic infectionHerpesvirus infectionMouse genetic modelsSTAT1T cell responses

Identifiers

PMID39894604
PMCPMC11788573

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.